FIELD: medicine, therapy.
SUBSTANCE: invention relates to a method for prognosis in lingering pneumonia course in patients with liver pathology that involves assay of bilirubin-aminotransferase index (BAI). The latter is calculated as a product of two ratios: activity of alanine aminotransferase to activity of aspartate aminotransferase and the content of serum bound bilirubin to the total bilirubin. The lingering pneumonia course is diagnosed at BAI value above 1. The measurement of BAI value allows carrying out prognosis for lingering pneumonia course in patients with liver pathology that promotes to the well-timed correction of treatment and improvement of the patient living quality.
EFFECT: improved method for prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RISK OF DEATH IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COMBINATION WITH COVID-19 | 2021 |
|
RU2764954C1 |
| METHOD OF EARLY RECOGNITION OF CHOLEDOCHOLITHIASIS | 2004 |
|
RU2256922C1 |
| METHOD OF CHRONIC HEPATITIS DIAGNOSIS | 0 |
|
SU1789930A1 |
| METHOD FOR SELECTING THE TYPE OF SURGICAL MANAGEMENT IN COAGULATED HEMOTHORAX PATIENTS | 2018 |
|
RU2701318C1 |
| METHOD FOR EVALUATING DISEASE SEVERITY IN CHILDREN | 2000 |
|
RU2184489C1 |
| METHOD FOR PREDICTING THE FLOW OF CHRONIC HEPATITIS C | 2003 |
|
RU2256925C1 |
| METHOD OF ASSESSING THE SEVERITY OF LIVER DYSFUNCTION IN CATTLE | 2022 |
|
RU2803003C1 |
| METHOD FOR ASSESSING THE FUNCTIONAL STATE OF THE LIVER OF CATTLE | 2021 |
|
RU2773414C1 |
| METHOD FOR PREDICTING OUTCOMES OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795095C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF LIVER PATHOLOGY | 0 |
|
SU1617376A1 |
